227 related articles for article (PubMed ID: 17637786)
1. Current status of allogeneic stem cell transplantation for treatment of hematologic malignancies.
Hart DP; Peggs KS
Clin Pharmacol Ther; 2007 Sep; 82(3):325-9. PubMed ID: 17637786
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
3. [Transfusion protocols in hematopoietic stem cell allogeneic transplantation].
Bardiaux L; Assari S; Babinet J; Cavelier B; Raba M; Redersdorff JC; Roubinet F
Transfus Clin Biol; 2007 May; 14(1):94-9. PubMed ID: 17521940
[TBL] [Abstract][Full Text] [Related]
4. Haematopoietic stem cell transplantation: current status.
Kumar L
Natl Med J India; 2007; 20(3):128-37. PubMed ID: 17867617
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals.
Kiss TL; Chang H; Daly A; Messner HA; Jamal N; Spaner D; Rubin S; Lipton JH
Bone Marrow Transplant; 2004 Apr; 33(8):855-8. PubMed ID: 14990983
[TBL] [Abstract][Full Text] [Related]
6. [Regenerative medicine for blood diseases].
Saito H
Nihon Rinsho; 2003 Mar; 61(3):494-7. PubMed ID: 12701179
[TBL] [Abstract][Full Text] [Related]
7. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
8. [Hematopoietic stem cell transplantation for hematologic disorders].
Tanosaki R
Nihon Rinsho; 2011 Dec; 69(12):2172-8. PubMed ID: 22242316
[TBL] [Abstract][Full Text] [Related]
9. New insights into cord blood stem cell transplantation.
Tse W; Bunting KD; Laughlin MJ
Curr Opin Hematol; 2008 Jul; 15(4):279-84. PubMed ID: 18536563
[TBL] [Abstract][Full Text] [Related]
10. Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency.
Kilpatrick DC; Stewart K; Allan EK; McLintock LA; Holyoake TL; Turner ML
Bone Marrow Transplant; 2005 Jan; 35(2):179-81. PubMed ID: 15543198
[TBL] [Abstract][Full Text] [Related]
11. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
[TBL] [Abstract][Full Text] [Related]
12. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
13. Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies.
Handgretinger R; Kurtzberg J; Egeler RM
Pediatr Clin North Am; 2008 Feb; 55(1):71-96, x. PubMed ID: 18242316
[TBL] [Abstract][Full Text] [Related]
14. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
[TBL] [Abstract][Full Text] [Related]
15. Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Alousi A; de Lima M
Clin Adv Hematol Oncol; 2007 Jul; 5(7):560-70. PubMed ID: 17679930
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow and peripheral blood stem cell transplantation for malignancy.
Johnson PW; Simnett SJ; Sweetenham JW; Morgan GJ; Stewart LA
Health Technol Assess; 1998; 2(8):1-187. PubMed ID: 9728295
[No Abstract] [Full Text] [Related]
17. Hematopoietic stem cell therapy for malignant diseases.
Shapira MY; Hai AA; Tsirigotis P; Resnick IB; Or R; Slavin S
Ann Med; 2007; 39(6):465-73. PubMed ID: 17852026
[TBL] [Abstract][Full Text] [Related]
18. [Physiopathology and possible clinical use of hematopoietic stem cells. Recent advances].
Testa U
Recenti Prog Med; 2009 Mar; 100(3):144-55. PubMed ID: 19475843
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
20. [Collection and transplantation of hematopoietic stem cells of circulating blood].
Körbling M; Fehrentz D; Rother K; Hunstein W
Beitr Infusionsther; 1988; 21():322-34. PubMed ID: 2463003
[No Abstract] [Full Text] [Related]
[Next] [New Search]